Insights for policymakers from a medicine price survey in Rajasthan

Indian Journal of Medical Research

Volumn 129, Issue 4, 2009, Pages 451-454

  Kotwani, Anita ^a   Gurbani, Nirmal ^b   Sharma, Sangeeta ^c   Chaudhury, R R ^d  

^a UNIVERSITY OF DELHI   (India)

^b Public Health Training Institute   (India)

^c INSTITUTE OF HUMAN BEHAVIOUR AND ALLIED SCIENCES   (India)

^d INDRAPRASTHA APOLLO HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ATENOLOL; DIAZEPAM; ENALAPRIL; FANSIDAR; GENERIC DRUG; GLIBENCLAMIDE; ESSENTIAL DRUG;

COST CONTROL; DIABETES MELLITUS; DRUG COST; DRUG MARKETING; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE POLICY; HYPERTENSION; INDIA; LETTER; PNEUMONIA; PUBLIC HEALTH SERVICE; PURCHASING; ECONOMICS; EPIDEMIOLOGY; HEALTH CARE DELIVERY; POLICY;

DRUGS, ESSENTIAL; HEALTH CARE SURVEYS; HEALTH SERVICES ACCESSIBILITY; INDIA; PUBLIC POLICY;

EID: 70149119777     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)

1. Everard M. Access to medicines in low-income countries. In: Dukes MNG, Haaijer-Ruskamp FM, Joncheere CP, Rietveld AH, editors. Drugs and money. The Netherlands: IOS Press Ohmsha (Published on behalf of WHO Regional office Europe), 2003. p. 137-49.
2. Creese A, Kotwani A, Kutzin J, Pillay A. Evaluating pharmaceuticals for health policy in low-and middle-income country settings. In: Freemantle N, Hill S, editors. Evaluating pharmaceuticals for health policy and reimbursement. Massachusetts, USA: Blackwell Publishing (in collaboration with WHO, Geneva); 2004. p. 227-43.
3. Health Action International Homepage. Health Action International, WHO, Medicine prices availability affordability & price components. A new approach to measurement, 2003 ed. Available at: http://www.haiweb.org/ medicineprices, accessed on January 4, 2006.
4. Kotwani A, Ewen M, Dey D, Iyer S, Lakshmi PK, Patel A, et al. Medicine Prices & availability of common medicines at six sites in India: using a standard methodology. Indian J Med Res 2007; 125: 645-54.
5. Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet 2009; 373: 240-9.
6. Management Sciences for Health. 2002. International drug price indicator guide. Available at: http://erc.msh.org, accessed on August 28, 2003.
7. The World Bank Group. World development indicators. http://devdata.worldbank.org/wdi2006/contents/section2.htm, accessed on August 17, 2008.
8. Government of India, National Pharmaceutical Pricing Authority homepages. Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers. http://www.nppaindia. nic.in/index1.html, accessed on February 6, 2008.